ARCHIVES

CTCs Do Not Affect Survival, But Could Signal Metastases

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

Nexavar Improves PFS In HER-2 Negative Breast Cancer

May 27, 2011

Funding Opportunity: Defense Department Offering $30.5 Mil In Research Grants

April 18, 2014

ImClone “Screwed Up,” CEO Waksal Tells Conference; Stock Plunges.

January 11, 2002

DCT Board Approves Recommendations For Clinical Trials; Some Controversial

November 9, 1979

New NCI Director Plans Greater Support For Translational Research, Collaboration.

March 1, 2002

RFAs For New Improve Accrual Of Minorities, Women

February 2, 1996